Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
63 Cards in this Set
- Front
- Back
Amino acids necessary for purine synthesis
|
glycine, aspartate, glutamine
|
|
Inhibits ribonucleotide reductase
|
Hydroxyurea blocks ribonucleotides --> deoxyribonucleotides
|
|
Inhibits thymidylate synthase
|
5-FU blocks dUMP --> dTMP
-Requires Me-THF -Regeneration of Me-THF requires dihydrofolate reductase |
|
Inhibits de novo purine synthesis
|
6-MP
|
|
Inhibits dihydrofolate reductase
|
Methotrexate
Trimethoprim (in bacteria) |
|
Defect in nucleotide excision repair
|
Xeroderma pigmentosum (AR)
-can't repair UV-induced thymine dimers -photosensitivity -prone to melanoma and other cancers Cockayne's Syndrome (AR) -cells unable to respond to UV dmage -accelerated aging of cells, bird-like facies |
|
Defect in mismatch repair genes
|
HNPCC (Lynch Syndrome) -- AD
-mutations in MSH2, MLH1 |
|
mRNA start codon
|
AUG (methionine)
|
|
mRNA stop codons
|
UGA, UAA, UAG
"U Go Away" "U Are Away" "U Are Gone" |
|
RNA processing
|
Occurs w/in nucleus:
1. 5' cap (Gpppp) 2. 3' Poly-A tail 3. Splicing (remove non-coding introns) via spliceosome |
|
Steps of splicing
|
1. Primary transcript (pre-mRNA) combines with snRNPs and other proteins to form spliceosome
2. Lariate-shaped intermediate generated 3. Lariate released to remove intron and join exons --> mRNA Exon - GU...A...AG - Exon |
|
TSGs that inhibit G1 --> S progression
|
Rb and p53
|
|
Rough ER
|
Site of synthesis of secretory proteins
-Goblet cells of SI (synthesize mucus) -Plasma cells (synthesize ab's) -Nissl bodies in neurons (synthesize peptide NTs) |
|
Smooth ER
|
Site of steroid synthesis and detoxification of poisons
-liver hepatocytes -adrenal cortex |
|
Vesicular trafficking proteins
|
COPI: retrograde, Golgi --> ER
COPII: anterograde, RER --> cis-Golgi Clathrin: trans-Golgi --> lysosomes Receptor mediated endocytosis |
|
I-cell disease
|
= Inclusion-cell disease
-inherited lysosomal storage disease -failure of addition of mannose-6-phosphate to lysosomal proteins --> enzymes are secreted outside cell i/o targeted to lysosome -coarse facial features, clouded corneas, restricted joint mvt -often fatal in childhood |
|
-coarse facial features, clouded corneas, restricted joint mvt
-often fatal in childhood |
I-cell disease
-inherited lysosomal storage disease -failure of addition of mannose-6-phosphate to lysosomal proteins --> enzymes are secreted outside cell i/o targeted to lysosome |
|
Microtubule structure & fxn
|
-Composed of tubulin dimers, each bound by 2 GTP
-Incorporated into flagella, cilia, mitotic spindles -Grow slowly, collapse quickly -Involved in axonal transport in neurons -Molecular motor proteins (dynein, kinesin) |
|
Molecular motor proteins
|
Transport cargo along microtubules
-Dynein - retrograde transport (+ --> -) -Kinesin - anterograde transport (- --> +) |
|
Drugs that act on microtubules
-anti-helminthic -anti-fungal -anti-cancer -anti-breast cancer -anti-gout |
-Mebendazole, thiabendazole (antihelminthic)
-Griseofulvin (antifungal) -Vincristine, vinblastine (anti-cancer) -Paclitaxel (anti-breast cancer) -Colchicine (anti-gout) |
|
Chediak-Higashi Syndrome
|
Microtubule polymerization defect --> decreased phagocytosis
-recurrent pyogenic infections, partial albinism, peripheral neuropathy |
|
Kartagener's Syndrome
|
-Immotile cilia due to dynein arm defect
1. Recurrent sinusitis, bronchiectasis 2. Infertility 3. Situs inversus |
|
GFAP stain
|
Neuroglial cells (especially astrocytes)
|
|
Neurofilament stain
|
Neurons
|
|
Cytokeratin stain
|
Epithelial cells
|
|
Vimentin stain
|
Connective tissue
|
|
Desmin stain
|
Muscle
|
|
Na+/K+ ATPase inhibitors
|
1. Ouabain (blocks K+ binding site)
2. Cardiac glycosides (digoxin, digitoxin) |
|
Type I collagen
|
BONE, tendon, skin, cornea
|
|
Type II collagen
|
CARTILAGE, nucleus pulposus
|
|
Type III collagen
|
Reticulin, blood vessels, granulation tissue
|
|
Type IV collagen
|
Basement membrane
|
|
Collagen synthesis
|
1. RER -- Synthesis of preprocollagen (Gly-X-Y polypeptide)
2. ER -- Post-translational hydroxylation of proline & lysine (requires vit C) 3. ER -- Post-translational glycosylation of lysine --> procollagen triple helix 4. Exocytosis & cleavage --> tropocollagen 5. Cross-linking --> collagen fibrils |
|
Ehlers Danlos Syndrome
|
Faulty collagen synthesis (usually type III) causing:
-hyperextensible skin -easy bruising -hypermobile joints -associated with berry aneurysms |
|
Osteogenesis Imperfecta (4 features)
|
Most common form is AD w/ abnormal type I collagen, causing:
-brittle bones-->multiple fractures -blue sclerae due to translucent CT over choroid -hearing loss due to abnormal middle ear bones -dental imperfections due to lack of dentin |
|
Scurvy
|
Vit. C deficiency --> inability to hydroxylate proline and lysine, causing:
-weakening of capillaries -gum ulceration, tissue hemorrhage, anemia, poor wound healing, loose teeth, corkscrew hairs |
|
Alport's syndrome
|
-X-linked recessive
-Results from abnormal type IV collagen -Progressive hereditary nephritis and deafness |
|
Congenital collagen diseases
|
Type I - Osteogenesis Imperfecta
Type II - ? Type III - Ehlers Danlos Syndrome Type IV - Alport's Syndrome |
|
Marfan Syndrome
|
-Autosomal dominant disorder
-Defect in fibrillin gene (FBN1) --> absence of elastin-associated fibrillin -bone elongation, arachnodactyly, hypermobile joints, lens dislocation -cardiac abnomalities (MVP), aortic dissection/rupture, aortic regurgitation, berry aneurysm |
|
Which cyclins correspond to which phases of the cell cycle?
|
G1 - Cyclin D increases
S - Cyclin E increases G2 - Cyclin B/A increases Mitosis |
|
Which anti-cancer drugs block nucleotide synthesis? (3 drugs)
|
1. Block thymidine synthesis
-5-FU inhibits thymidylate synthase -Methotrexate inhibits DHF reductase 2. 6-MP blocks de novo purine synthesis |
|
Which anti-cancer drugs cross-link DNA? (2 drugs)
|
1. alkylating agents
2. cisplatin |
|
Which anti-cancer drugs intercalate DNA? (2 drugs)
|
1. dactinomycin
2. doxorubicin (adriamycin) |
|
Which anti-cancer drugs inhibit topoisomerase II? (1 drug)
|
1. Etoposide
|
|
Which anti-cancer drugs interfere with microtubule formation and/or disassembly? (3 drugs)
|
1. Vinca alkaloids (vincristine, vinblastine) block microtubule formation
2. Paclitaxel blocks microtubule disassembly |
|
Leucovorin (folinic acid) rescue is effective with which drug?
|
MTX ... b/c it provides an exogenous source of THF, thereby overwhelming block of DHF reductase.
NOT effective with 5-FU |
|
Blocks de novo purine synthesis. Activated by HGPRTase.
|
6-MP
Note: metabolized by xanthine oxidase; thus, increased toxicity with allopurinol |
|
Alkylating agents? (3)
|
1. Cyclophosphamide, ifosfamide
2. Nitrosoureas (carmustine, lomustine, etc.) 3. Busulfan |
|
Used in colon cancer and other solid tumors
|
5-FU
|
|
Used to treat brain tumors (including glioblastoma multiforme)
|
Nitrosoureas (carmustine, lomustine, semustine, etc)
-alkylating agents -cross BBB -Can cause CNS toxicity |
|
Used to treat testicular, bladder, ovary, and lung carcinomas
|
Cisplatin, carboplatin
-cross-link DNA -can cause nephrotoxicity and acoustic nerve damage |
|
Used to ablate bone marrow b/f HSC transplant
|
Busulfan
-alkylates DNA -can cause pulmonary fibrosis, hyperpigmentation |
|
ABVD combination for Hodgkins lymphoma
|
Adriamycin (doxorubicin) = intercalating agent, generates free radicals --> breaks
Bleomycin = generates free radicals --> breaks Vinblastine = blocks polymerization of microtubules Decarbazine = alkylating agent |
|
Used in childhood tumors (Wilms' tumor, Ewing's sarcoma, rhabdomyosarcoma)
|
Dactinomycin (Actinomycin D)
"Children ACT out" |
|
Side effect of bleomycin
|
Pulmonary fibrosis, skin changes
Other drugs that cause pulmonary fibrosis: amiodarone, |
|
Inhibits ribonucleotide reductase
|
hydroxyurea
-used in melanoma, sickle cell disease (increased HbF) |
|
Inhibits topoisomerase II --> increased DNA degradation
|
Etoposide
|
|
Used in estrogen receptor + breast cancers and osteoporosis
|
SERMs = receptor antagonists in breast, agonists in bone
1. Tamoxifen (may increase risk of endometrial carcinoma b/c endometrial partial agonist) 2. Raloxifene (does nOT cause endometrial carcinoma b/c endometrial antagonist) |
|
Monoclonal antibody against HER-2 (erb-B2)
|
Trastazumab (herceptin)
-cardiotoxicity |
|
Used in CML, GI stromal tumors
|
Imatinib (Gleevec)
-BCR-ABL fusion tyrosine kinase inhibitor |
|
Used in ovarian and breast carcinomas
|
Paclitaxel, -taxols
-hyperstabilizes polymerized microtubules so they cannot break down (i.e. anaphase cannot occur) |
|
What are psammoma bodies and in which tumors are they found?
|
PSaMMoma bodies:
-Form around single necrotic cells -Small laminated, concentric spherules containing calcium -Found in... Papillary carcinoma of thyroid Serous papillary cystadenocarcinoma of ovary Meningioma Mesothelioma |
|
Helps to improve appetite in pts receiving anti-neoplastic therapy
|
Megestrol acetate
|